News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
82,660 Results
Type
Article (9606)
Company Profile (51)
Press Release (73003)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (21750)
Career Advice (107)
Deals (3070)
Drug Delivery (10)
Drug Development (12231)
Employer Resources (14)
FDA (1770)
Job Trends (2219)
News (37770)
Policy (3151)
Tag
2027 Genetown Elite (1)
2027 Genetown Standard (1)
Academia (649)
Accelerated approval (9)
Adcomms (5)
Allergies (10)
Alliances (6919)
ALS (39)
Alzheimer's disease (314)
Antibody-drug conjugate (ADC) (19)
Approvals (1816)
Artificial intelligence (74)
Autoimmune disease (14)
Automation (5)
Bankruptcy (15)
Best Places to Work (2113)
BIOSECURE Act (3)
Biosimilars (9)
Biotechnology (44)
Bladder cancer (21)
Brain cancer (20)
Breast cancer (64)
Cancer (682)
Cardiovascular disease (94)
Career advice (93)
Career pathing (2)
CAR-T (62)
Celiac Disease (1)
Cell therapy (185)
Clinical research (9875)
Collaboration (338)
Compensation (180)
Complete response letters (15)
COVID-19 (379)
CRISPR (55)
C-suite (132)
Cystic fibrosis (91)
Data (1223)
Denatured (1)
Depression (9)
Diabetes (61)
Diagnostics (1539)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (51)
Drug pricing (4)
Duchenne muscular dystrophy (113)
Earnings (7117)
Editorial (8)
Employer branding (3)
Employer resources (13)
Events (12547)
Executive appointments (118)
FDA (2288)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (11)
Funding (217)
Gene editing (133)
Generative AI (4)
Gene therapy (324)
GLP-1 (99)
Government (491)
Grass and pollen (1)
Guidances (57)
Healthcare (2320)
HIV (10)
Huntington's disease (21)
IgA nephropathy (15)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (15)
Infectious disease (405)
Inflammatory bowel disease (32)
Inflation Reduction Act (1)
Influenza (6)
Intellectual property (26)
Interviews (14)
IPO (1584)
IRA (1)
Job creations (265)
Job search strategy (89)
JPM (7)
Kidney cancer (1)
Labor market (3)
Layoffs (59)
Legal (395)
Liver cancer (10)
Longevity (2)
Lung cancer (80)
Lymphoma (86)
Machine learning (6)
Management (1)
Manufacturing (104)
MASH (6)
Medical device (295)
Medtech (295)
Mergers & acquisitions (1616)
Metabolic disorders (166)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (74)
Neuropsychiatric disorders (6)
Neuroscience (550)
NextGen: Class of 2026 (733)
Non-profit (678)
Now hiring (5)
Obesity (89)
Opinion (49)
Ovarian cancer (10)
Pain (13)
Pancreatic cancer (27)
Parkinson's disease (64)
Partnered (2)
Patents (46)
Patient recruitment (68)
Peanut (1)
People (7284)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (3795)
Phase 2 (4516)
Phase 3 (3172)
Pipeline (856)
Policy (19)
Postmarket research (212)
Preclinical (1709)
Press Release (18)
Prostate cancer (25)
Psychedelics (3)
Radiopharmaceuticals (18)
Rare diseases (433)
Real estate (499)
Recruiting (3)
Regulatory (2976)
Reports (9)
Research institute (781)
Resumes & cover letters (11)
Rett syndrome (26)
RNA editing (11)
RSV (3)
Schizophrenia (12)
Series A (37)
Series B (34)
Service/supplier (1)
Sickle cell disease (46)
Special edition (3)
Spinal muscular atrophy (139)
Sponsored (6)
Startups (621)
Supply chain (6)
Tariffs (2)
The Weekly (6)
Vaccines (93)
Venture capital (11)
Weight loss (32)
Women's health (9)
Date
Today (25)
Last 7 days (91)
Last 30 days (320)
Last 365 days (4618)
2026 (484)
2025 (4674)
2024 (5491)
2023 (5855)
2022 (7883)
2021 (8233)
2020 (6731)
2019 (5469)
2018 (4084)
2017 (4213)
2016 (3772)
2015 (4352)
2014 (3055)
2013 (2421)
2012 (2190)
2011 (2176)
2010 (1910)
Location
Africa (95)
Alabama (4)
Alaska (2)
Arizona (16)
Arkansas (1)
Asia (3945)
Australia (764)
California (1827)
Canada (321)
China (111)
Colorado (67)
Connecticut (53)
Delaware (23)
Europe (10903)
Florida (173)
Georgia (16)
Hawaii (1)
Idaho (4)
Illinois (57)
India (4)
Indiana (167)
Iowa (3)
Japan (87)
Kansas (6)
Kentucky (4)
Louisiana (6)
Maine (3)
Maryland (179)
Massachusetts (1832)
Michigan (74)
Minnesota (21)
Missouri (4)
Montana (2)
Nebraska (4)
Nevada (14)
New Hampshire (3)
New Jersey (291)
New Mexico (4)
New York (459)
North Carolina (238)
North Dakota (5)
Northern California (962)
Ohio (53)
Oklahoma (1)
Oregon (4)
Pennsylvania (335)
Puerto Rico (2)
Rhode Island (7)
South America (121)
South Carolina (3)
Southern California (661)
Tennessee (5)
Texas (248)
United States (6353)
Utah (140)
Virginia (55)
Washington D.C. (10)
Washington State (160)
Wisconsin (12)
82,660 Results for "opus genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 2, 2026
·
2 min read
Press Releases
Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
January 8, 2026
·
8 min read
Press Releases
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
January 27, 2026
·
6 min read
Press Releases
Opus Genetics to Participate in Upcoming Investment Conferences
November 21, 2025
·
1 min read
Press Releases
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
December 11, 2025
·
1 min read
Press Releases
Opus Genetics Announces $23 Million Registered Direct Offering
November 6, 2025
·
5 min read
Press Releases
Opus Genetics to Participate in Chardan’s 9th Annual Genetic Medicines Conference
October 15, 2025
·
1 min read
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 16, 2025
December 17, 2025
·
2 min read
Press Releases
Opus Genetics Announces Financial Results for Third Quarter 2025 and Provides Corporate Update
November 13, 2025
·
12 min read
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 2, 2025
December 3, 2025
·
2 min read
1 of 8,266
Next
